Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials-Reference-Cited by-同舟云学术

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials

Published:2021-05 Issue:5 Volume:9 Page:467-475
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Theelen Willemijn S M E,Chen Dawei,Verma Vivek,Hobbs Brian P,Peulen Heike M U,Aerts Joachim G J V,Bahce Idris,Niemeijer Anna Larissa N,Chang Joe Y,de Groot Patricia M,Nguyen Quynh-Nhu,Comeaux Nathan I,Simon George R,Skoulidis Ferdinandos,Lin Steven H,He Kewen,Patel Roshal,Heymach John,Baas Paul,Welsh James W

Funder

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference20 articles.

1. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer;Gandhi;N Engl J Med,2018

2. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial;Mok;Lancet,2019

3. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer;Paz-Ares;N Engl J Med,2018

4. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

5. Five-year overall survival for patients with advanced nonsmall-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study;Garon;J Clin Oncol,2019

Cited by 349 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into immune cells modulation of tumor resistance;Critical Reviews in Oncology/Hematology;2024-10

2. Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors;Radiotherapy and Oncology;2024-10

3. Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer;Cancers;2024-09-11

4. Epigenetic modification in radiotherapy and immunotherapy for cancers;Tzu Chi Medical Journal;2024-09-05

5. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy;Biomarker Research;2024-09-04